298 related articles for article (PubMed ID: 19285259)
1. Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance.
Borrelli F; Izzo AA
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):33-49. PubMed ID: 19285259
[TBL] [Abstract][Full Text] [Related]
2. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
Ho WS; Barrett DA; Randall MD
Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
[TBL] [Abstract][Full Text] [Related]
3. N-acylethanolamines, anandamide and food intake.
Hansen HS; Diep TA
Biochem Pharmacol; 2009 Sep; 78(6):553-60. PubMed ID: 19413995
[TBL] [Abstract][Full Text] [Related]
4. Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells.
Matias I; Gonthier MP; Petrosino S; Docimo L; Capasso R; Hoareau L; Monteleone P; Roche R; Izzo AA; Di Marzo V
Br J Pharmacol; 2007 Nov; 152(5):676-90. PubMed ID: 17704823
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide.
Capasso R; Izzo AA
J Neuroendocrinol; 2008 May; 20 Suppl 1():39-46. PubMed ID: 18426498
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.
Hansen HS
Exp Neurol; 2010 Jul; 224(1):48-55. PubMed ID: 20353771
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
[TBL] [Abstract][Full Text] [Related]
8. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
[TBL] [Abstract][Full Text] [Related]
9. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
[TBL] [Abstract][Full Text] [Related]
10. [The endocannabinoid system and food intake control].
Rodríguez de Fonseca F
Rev Med Univ Navarra; 2004; 48(2):18-23. PubMed ID: 15382609
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry.
Lam PM; Marczylo TH; Konje JC
Anal Bioanal Chem; 2010 Nov; 398(5):2089-97. PubMed ID: 20835819
[TBL] [Abstract][Full Text] [Related]
12. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice.
Aviello G; Matias I; Capasso R; Petrosino S; Borrelli F; Orlando P; Romano B; Capasso F; Di Marzo V; Izzo AA
J Mol Med (Berl); 2008 Apr; 86(4):413-22. PubMed ID: 18278475
[TBL] [Abstract][Full Text] [Related]
15. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.
Costa B; Comelli F; Bettoni I; Colleoni M; Giagnoni G
Pain; 2008 Oct; 139(3):541-550. PubMed ID: 18602217
[TBL] [Abstract][Full Text] [Related]
16. Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study.
Drummen M; Tischmann L; Gatta-Cherifi B; Cota D; Matias I; Raben A; Adam T; Westerterp-Plantenga M
J Clin Endocrinol Metab; 2020 Jul; 105(7):e2511-20. PubMed ID: 32333763
[TBL] [Abstract][Full Text] [Related]
17. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
[TBL] [Abstract][Full Text] [Related]
18. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
19. Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure.
Jumpertz R; Guijarro A; Pratley RE; Piomelli D; Krakoff J
J Clin Endocrinol Metab; 2011 Mar; 96(3):787-91. PubMed ID: 21177788
[TBL] [Abstract][Full Text] [Related]
20. FAAH deficiency promotes energy storage and enhances the motivation for food.
Touriño C; Oveisi F; Lockney J; Piomelli D; Maldonado R
Int J Obes (Lond); 2010 Mar; 34(3):557-68. PubMed ID: 20029375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
